Cytokinetics Inc (CYTK)
66.35
-1.20
(-1.78%)
USD |
NASDAQ |
Apr 22, 16:00
66.27
-0.08
(-0.12%)
After-Hours: 20:00
Cytokinetics Gross Profit Margin (Quarterly): -4.98K% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.98K% |
| September 30, 2023 | -21.73K% |
| June 30, 2023 | -9.50K% |
| March 31, 2023 | -1.62K% |
| December 31, 2022 | -3.73K% |
| September 30, 2022 | -2.39K% |
| June 30, 2022 | 35.79% |
| March 31, 2022 | -3.90K% |
| December 31, 2021 | 21.77% |
| September 30, 2021 | -790.9% |
| June 30, 2021 | -1.18K% |
| March 31, 2021 | -382.0% |
| December 31, 2020 | -334.7% |
| September 30, 2020 | 41.94% |
| June 30, 2020 | -506.5% |
| March 31, 2020 | -468.3% |
| December 31, 2019 | -251.8% |
| September 30, 2019 | -234.1% |
| June 30, 2019 | -236.5% |
| March 31, 2019 | -178.2% |
| December 31, 2018 | -148.2% |
| September 30, 2018 | -101.0% |
| June 30, 2018 | -247.3% |
| March 31, 2018 | -320.2% |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | -303.7% |
| June 30, 2017 | -548.8% |
| March 31, 2017 | -364.5% |
| December 31, 2016 | 43.34% |
| September 30, 2016 | 69.74% |
| June 30, 2016 | -67.58% |
| March 31, 2016 | -60.72% |
| December 31, 2015 | -35.79% |
| September 30, 2015 | -45.46% |
| June 30, 2015 | -93.15% |
| March 31, 2015 | -102.9% |
| December 31, 2014 | 59.65% |
| September 30, 2014 | -21.30% |
| June 30, 2014 | -50.71% |
| March 31, 2014 | -56.54% |
| December 31, 2013 | 43.23% |
| September 30, 2013 | -200.9% |
| June 30, 2013 | -1.12K% |
| March 31, 2013 | -1.10K% |
| December 31, 2012 | -351.4% |
| September 30, 2012 | -413.3% |
| June 30, 2012 | -347.7% |
| March 31, 2012 | -380.5% |
| December 31, 2011 | -4.81K% |
| September 30, 2011 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-21.73K%
Minimum
Sep 2023
41.94%
Maximum
Sep 2020
-2.74K%
Average
-506.5%
Median
Jun 2020
Gross Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 62.03% |
| Johnson & Johnson | 69.55% |
| Eli Lilly and Co | 80.88% |
| Viking Therapeutics Inc | -- |
| Madrigal Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -61.92% |
| Return on Invested Capital | -168.4% |
| Profit Margin (Quarterly) | -8.19K% |
| Operating Margin (Quarterly) | -7.62K% |
| Return on Net Operating Assets | -332.6% |